These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 32759166

  • 1. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.
    Zhu X, Yan H, Chang X, Xia M, Zhang L, Wang L, Sun X, Yang X, Gao X, Bian H.
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32759166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
    Zhang W, Li Y, Li S, Zhou J, Wang K, Li Z, Chen N, Chen X.
    Front Endocrinol (Lausanne); 2023 Aug; 14():1278505. PubMed ID: 38116314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.
    Moon SS, Lee YS, Kim SW.
    Endocrine; 2012 Oct; 42(2):423-9. PubMed ID: 22407492
    [Abstract] [Full Text] [Related]

  • 7. Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women.
    Lee DY, Park JK, Hur KY, Um SH.
    Climacteric; 2018 Oct; 21(5):498-501. PubMed ID: 30122075
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease.
    Barchetta I, Lubrano C, Cimini FA, Dule S, Passarella G, Dellanno A, Di Biasio A, Leonetti F, Silecchia G, Lenzi A, Cavallo MG.
    Hepatol Int; 2023 Apr; 17(2):357-366. PubMed ID: 36520377
    [Abstract] [Full Text] [Related]

  • 12. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
    Pacifico L, Bezzi M, Lombardo CV, Romaggioli S, Ferraro F, Bascetta S, Chiesa C.
    World J Gastroenterol; 2013 Jul 07; 19(25):4007-14. PubMed ID: 23840146
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.
    Lee SH, Yun JM, Kim SH, Seo YG, Min H, Chung E, Bae YS, Ryou IS, Cho B.
    J Endocrinol Invest; 2016 Nov 07; 39(11):1329-1336. PubMed ID: 27561910
    [Abstract] [Full Text] [Related]

  • 16. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Ahn SH, Seo DH, Kim SH, Nam MS, Hong S.
    Osteoporos Int; 2018 Jan 07; 29(1):181-190. PubMed ID: 29051986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.